Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-09-19

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP®

The main questions it aims to answer are:

* The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient
* The adherence profile of each patient
* The association between the adherence profile, the objective adherence data and the clinical data.

Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma

NCT04552964

Glaucoma

COMPLETED NA

A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications

NCT03506568

Medication Adherence Glaucoma

COMPLETED NA

Steroid Eyedrop Adherence After Trabeculectomy

NCT03402802

Glaucoma Adherence, Patient

COMPLETED

A Study for Assessing the Safety of Hanita Glaucoma Shunt in Glaucoma Patients

NCT04796883

Glaucoma

COMPLETED NA

Value of an Intervention to Enhance Adherence in Glaucoma Patients

NCT00756184

Glaucoma

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adherence to Glaucoma Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group receiving T9060 CONNECTDROP

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (≥ 18 years old), man or woman
* Patient with a diagnosis of bilateral open angle glaucoma
* Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.
* Patient willing to participate in the study
* Patient who consents for data collection in the frame of the study

Exclusion Criteria

* Pregnant and/or lactating woman
* Patient receiving another ocular treatment for a chronic condition (i.e. regular instillations for several months)
* Protected patient: adult under guardianship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.